Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 2/20 | 0.45 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.45 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4396782 | 0.93 | GNAI3 (0.42) | GNAI3GNAO1GNAI1HRH3PAOX | |
| SCHEMBL6659172 | 0.88 | GNAI3 (0.54) | GNAI3GNAO1GNAI1HRH3PAOX | |
| SCHEMBL4395677 | 0.86 | GNAO1 (0.55) | GNAI3GNAO1GNAI1HRH3KDM4E | |
| SCHEMBL4400509 | 0.86 | GNAI3 (0.50) | GNAI3GNAO1GNAI1HRH3PAOX | |
| SCHEMBL6663102 | 0.85 | GNAI3 (0.50) | GNAI3GNAO1GNAI1HRH3KDM4E | |
| SCHEMBL4392289 | 0.84 | PAOX (0.53) | GNAI3GNAO1GNAI1HRH3PAOX | |
| SCHEMBL4399956 | 0.83 | SIGMAR1 (0.36) | GNAI3GNAO1GNAI1KDM4EALDH1A1 | |
| SCHEMBL11736163 | 0.81 | GNAO1 (0.65) | GNAI3GNAO1GNAI1HRH3KDM4E | |
| SCHEMBL11737731 | 0.81 | GNAO1 (0.65) | GNAI3GNAO1GNAI1HRH3KDM4E | |
| SCHEMBL15384686 | 0.81 | GNAO1 (0.65) | GNAI3GNAO1GNAI1HRH3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | MITSUI CHEMICALS, INC. (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20070054084-A1 | Optical recording medium and compound used for the same | MITSUI CHEMICALS, INC. (JP) | 2007-03-08 | — | — | US | disclosed |
| EP-1672626-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED IN THE OPTICAL RECORDING MEDIUM | Mitsui Chemicals, Inc. (JP) | 2006-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | CACNA1B, KCNN4, KCNN2 | GNAI3 881/4885GNAO1 191/4885GNAI1 1073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.